Grape King Bio (TPE:1707) Total Debt per Share: NT$1.26 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1707 Grape King Bio Ltd TPE:1707
81 GF Score
Price NT$89.40
GF Value NT$134.21
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Grape King Bio Total Debt per Share?

Grape King Bio TPE:1707 +0.11% 81 Total Debt per Share is NT$1.26 as of Jun. 2026. GuruFocus rates TPE:1707 with a GF Score™ of 81/100 and a GF Value™ of NT$134.21 (Significantly Undervalued). The stock has 4 warning signs investors should review.

NT$1.26 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Grape King Bio's Total Debt Per Share for the quarter that ended in Jun. 2026 was NT$1.26.


Grape King Bio Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Grape King Bio's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grape King Bio Total Debt per Share Chart

Grape King Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.84 1.07 1.30 1.09 1.45

Grape King Bio Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.67 1.56 1.45 1.35 1.26
TPE:1707
81GF Score
Grape King Bio Ltd TPE:1707
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grape King Bio Total Debt per Share Calculation

Grape King Bio's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Grape King Bio's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of NT$1.26 mean?
Grape King Bio (TPE:1707) has a Total Debt per Share of NT$1.26 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Grape King Bio and its competitors.
Is Grape King Bio's Total Debt per Share too high?
Grape King Bio's current Total Debt per Share is NT$1.26. Overall, Grape King Bio has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Grape King Bio's Total Debt per Share compare to ZTS?
Grape King Bio's Total Debt per Share of NT$1.26 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Drug Manufacturers company?
A good Total Debt per Share depends on the Drug Manufacturers industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Grape King Bio and its competitors. Grape King Bio's current Total Debt per Share is NT$1.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grape King Bio stock overvalued right now?
Based on GuruFocus' analysis, Grape King Bio (TPE:1707) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$134.21, compared to a current price of NT$89.40 — trading 33.4% below its estimated fair value. The current Total Debt per Share is NT$1.26. Grape King Bio's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Grape King Bio (TPE:1707), the current Total Debt per Share is NT$1.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grape King Bio (TPE:1707) Overvalued in 2026?

Based on GuruFocus' analysis, Grape King Bio stock appears to be undervalued. The current stock price of NT$89.40 is trading 33.4% below its estimated GF Value™ of NT$134.21. GuruFocus considers Grape King Bio to be Significantly Undervalued.

Key valuation signals for TPE:1707:

  • Total Debt per Share: NT$1.26
  • GF Value™: NT$134.21 vs. price of NT$89.40 (33.4% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the TPE:1707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Grape King Bio Business Description

Address Jinling Road, No. 402, Section 2, Pingzhen District, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food. The company has three segments: MLM (Multi-Level Marketing), which is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, the Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
81GF Score

Get the complete analysis for TPE:1707

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$89.40
Price
NT$134.21
GF Value